Re-sculpting the Pfizer Screening File
Dr. Andy Bell, Research Fellow at Sandwich Laboratories Worldwide R&D, Pfizer, shares his insights on Pfizer's review of their screening file, prior to the merger with Wyeth in 2009. He also discusses with Pharma IQ, how they identified areas where improvements could be made to the quality of the collection.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.